Levetiracetam Sandoz (Levetiracetam)

Levetiracetam exerts its effect by binding to the synaptic vesicle protein SV2A, which modulates the release of neurotransmitters. This binding stabilizes neuronal activity, reduces excessive neuronal firing, and diminishes the propagation of epileptic discharges, thereby contributing to seizure control.

The appropriate dose of Levetiracetam Sandoz is individualized by the prescribing healthcare professional based on the patient’s age, weight, renal function, seizure type, and response to therapy. Patients should follow the dosage instructions provided by their prescriber and not adjust the dose without medical guidance.

Safety data for levetiracetam in pregnancy and lactation are limited. Clinicians should weigh the potential benefits of seizure control against any possible risks to the fetus or infant. If treatment is necessary, it should be prescribed at the lowest effective dose, and patients should discuss breastfeeding considerations with their healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity of Levetiracetam Sandoz. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Compared with older antiepileptics such as carbamazepine or valproate, levetiracetam has a relatively favorable drug‑interaction profile and does not require routine therapeutic drug monitoring. It is often chosen for patients who need a medication with fewer enzyme‑inducing effects, though individual response and tolerability vary among patients.

Levetiracetam Sandoz tablets should be stored at ambient temperature, below 25 °C, in the original packaging to protect them from moisture and light. Keep the product out of reach of children and avoid storing in areas with high humidity or direct sunlight.

Levetiracetam Sandoz is taken orally, usually with or without food, as directed by the prescriber. Tablets should be swallowed whole with a glass of water. The dosing schedule (once, twice, or multiple times daily) depends on the individual treatment plan established by the healthcare professional.

Serious adverse events, although rare, include severe allergic reactions (such as Stevens‑Johnson syndrome), significant mood changes including depression or suicidal thoughts, and hematologic abnormalities like low white‑blood‑cell or platelet counts. Patients should seek immediate medical attention if they experience rash, mood swings, or signs of infection.

Levetiracetam Sandoz is contraindicated in individuals with known hypersensitivity to levetiracetam or any of the tablet’s excipients. Caution is advised for patients with severe renal impairment, uncontrolled psychiatric conditions, or those taking medications that may markedly reduce its plasma concentration without appropriate monitoring.